BACKGROUND: Drug use (illicit drug use and nonmedical use of prescription drugs) is common but underrecognized in primary care settings. We validated a single-question screening test for drug use and drug use disorders in primary care. METHODS: Adult patients recruited from primary care waiting rooms were asked the single screening question, "How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?" A response of at least 1 time was considered positive for drug use. They were also asked the 10-item Drug Abuse Screening Test (DAST-10). The reference standard was the presence or absence of current (past year) drug use or a drug use disorder (abuse or dependence) as determined by a standardized diagnostic interview. Drug use was also determined by oral fluid testing for common drugs of abuse. RESULTS: Of 394 eligible primary care patients, 286 (73%) completed the interview. The single screening question was 100% sensitive (95% confidence interval [CI], 90.6%-100%) and 73.5% specific (95% CI, 67.7%-78.6%) for the detection of a drug use disorder. It was less sensitive for the detection of self-reported current drug use (92.9%; 95% CI, 86.1%-96.5%) and drug use detected by oral fluid testing or self-report (81.8%; 95% CI, 72.5%-88.5%). Test characteristics were similar to those of the DAST-10 and were affected very little by participant demographic characteristics. CONCLUSION: The single screening question accurately identified drug use in this sample of primary care patients, supporting the usefulness of this brief screen in primary care.
BACKGROUND: Drug use (illicit drug use and nonmedical use of prescription drugs) is common but underrecognized in primary care settings. We validated a single-question screening test for drug use and drug use disorders in primary care. METHODS: Adult patients recruited from primary care waiting rooms were asked the single screening question, "How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?" A response of at least 1 time was considered positive for drug use. They were also asked the 10-item Drug Abuse Screening Test (DAST-10). The reference standard was the presence or absence of current (past year) drug use or a drug use disorder (abuse or dependence) as determined by a standardized diagnostic interview. Drug use was also determined by oral fluid testing for common drugs of abuse. RESULTS: Of 394 eligible primary care patients, 286 (73%) completed the interview. The single screening question was 100% sensitive (95% confidence interval [CI], 90.6%-100%) and 73.5% specific (95% CI, 67.7%-78.6%) for the detection of a drug use disorder. It was less sensitive for the detection of self-reported current drug use (92.9%; 95% CI, 86.1%-96.5%) and drug use detected by oral fluid testing or self-report (81.8%; 95% CI, 72.5%-88.5%). Test characteristics were similar to those of the DAST-10 and were affected very little by participant demographic characteristics. CONCLUSION: The single screening question accurately identified drug use in this sample of primary care patients, supporting the usefulness of this brief screen in primary care.
Authors: R S Niedbala; K W Kardos; D F Fritch; S Kardos; T Fries; J Waga; J Robb; E J Cone Journal: J Anal Toxicol Date: 2001 Jul-Aug Impact factor: 3.367
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: Edward J Cone; Lance Presley; Michael Lehrer; William Seiter; Melissa Smith; Keith W Kardos; Dean Fritch; Sal Salamone; R Sam Niedbala Journal: J Anal Toxicol Date: 2002 Nov-Dec Impact factor: 3.367
Authors: Daniel P Alford; Erin E Krebs; Ian A Chen; Christina Nicolaidis; Matthew J Bair; Jane Liebschutz Journal: J Gen Intern Med Date: 2010-07-15 Impact factor: 5.128
Authors: Stefan G Kertesz; Yulia Khodneva; Joshua Richman; Jalie A Tucker; Monika M Safford; Bobby Jones; Joseph Schumacher; Mark J Pletcher Journal: J Gen Intern Med Date: 2012-01-25 Impact factor: 5.128
Authors: Patti L Ephraim; Felicia Hill-Briggs; Debra L Roter; Lee R Bone; Jennifer L Wolff; LaPricia Lewis-Boyer; David M Levine; Hanan J Aboumatar; Lisa A Cooper; Stephanie J Fitzpatrick; Kimberly A Gudzune; Michael C Albert; Dwyan Monroe; Michelle Simmons; Debra Hickman; Leon Purnell; Annette Fisher; Richard Matens; Gary J Noronha; Peter J Fagan; Hema C Ramamurthi; Jessica M Ameling; Jeanne Charlston; Tanyka S Sam; Kathryn A Carson; Nae-Yuh Wang; Deidra C Crews; Raquel C Greer; Valerie Sneed; Sarah J Flynn; Nicole DePasquale; L Ebony Boulware Journal: Contemp Clin Trials Date: 2014-06-21 Impact factor: 2.226
Authors: Onyema Ogbuagu; Brandon D L Marshall; Perry Tiberio; Adedotun Ogunbajo; Lydia Barakat; Madeline Montgomery; Alexi Almonte; Tyler Wray; Emily C Williams; E Jennifer Edelman; Philip A Chan Journal: AIDS Behav Date: 2019-01
Authors: Hector P Rodriguez; Beth A Glenn; Tanya T Olmos; Alex H Krist; Stephanie L Shimada; Rodger Kessler; Suzanne Heurtin-Roberts; Roshan Bastani Journal: J Am Board Fam Med Date: 2014 May-Jun Impact factor: 2.657
Authors: Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin Journal: JAMA Date: 2014-08-06 Impact factor: 56.272